Alcohol Septal Ablation for Hypertrophic ... - summitMD.com

More documents

Recommendations

Info

Survival Rate (%) Survival Curve 100 80 60 40 20 91.9 % 85.4 % 0 6 12 18 24 30 36 Follow Up Duration ( Months ) CardioVascular Research Foundation
Conclusions • AST is a promising nonsurgical technique for septal myocardial reduction in HOCM. • Major complications was related to a large amount of alcohol injection (>4 ml), and hemodynamic recurrence was related to insufficient infarction. • Taken together, target artery and ethanol dose (2-3ml) should be carefully selected to get the therapeutic benefits without major complications. CardioVascular Research Foundation
Page 1 and 2: Alcohol Septal Ablation for Hypertr
Page 3 and 4: Limitations of AST • Potential se
Page 5 and 6: Purpose • To investigate the inci
Page 7 and 8: Study Patients Between December 199
Page 9 and 10: Myocardial Contrast Echocardiograph
Page 11 and 12: Post-ablation Management • Patien
Page 13 and 14: Follow Up • Clinical follow-up ev
Page 15 and 16: Echocardiographic Data Baseline Imm
Page 17 and 18: Hemodynamic Recurrence Number of pa
Page 19 and 20: Determinants of Hemodynamic Recurre
Page 21 and 22: Recurrence of LVOT Obstruction Sens
Page 23 and 24: Early Complications • Death due t
Page 25: Long-term Follow up • Follow up d
Page 29 and 30: Effect of LVOT on Clinical Outcome
Page 31 and 32: Myocardial Contrast Echocardiograph
Page 33 and 34: Mean NYHA & CCS Class before and af
Page 35 and 36: 100 LV Remodeling After ASA * * Sep
Page 37 and 38: Alcohol Septal Ablation vs Surgical
Page 39 and 40: Complications (Systematic Review) N
Page 41: Summary • ASA is a promising nons

Alcohol Septal Ablation for Hypertrophic ... - summitMD.com

Create successful ePaper yourself

Delete template?

Save as template?